Correlation Between Third Harmonic and Amylyx Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Third Harmonic and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Third Harmonic and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Third Harmonic Bio and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Third Harmonic and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Third Harmonic with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Third Harmonic and Amylyx Pharmaceuticals.

Diversification Opportunities for Third Harmonic and Amylyx Pharmaceuticals

0.76

Correlation Coefficient

Third Harmonic  Amylyx Pharmaceuticals

Poor diversification

The 3 months correlation between Third and Amylyx is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Third Harmonic Bio and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Third Harmonic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Third Harmonic Bio are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Third Harmonic i.e., Third Harmonic and Amylyx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Third Harmonic and Amylyx Pharmaceuticals

Given the investment horizon of 90 days Third Harmonic is expected to generate 11.51 times less return on investment than Amylyx Pharmaceuticals. But when comparing it to its historical volatility, Third Harmonic Bio is 11.01 times less risky than Amylyx Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  515.00  in Amylyx Pharmaceuticals on May 5, 2025 and sell it today you would earn a total of  257.00  from holding Amylyx Pharmaceuticals or generate 49.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Third Harmonic Bio  vs.  Amylyx Pharmaceuticals

Third Harmonic Bio

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Third Harmonic Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Third Harmonic is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Amylyx Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Third Harmonic and Amylyx Pharmaceuticals

The main advantage of trading using opposite Third Harmonic and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Third Harmonic position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.

The idea behind Third Harmonic Bio and Amylyx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.